The (5th Edition, 2025) is the authoritative global standard for diagnosing and categorizing cutaneous neoplasms. Also known as the "Blue Books," this edition shifts toward a more integrated, multidisciplinary approach that combines traditional histopathology with advanced molecular genetics and immunohistochemistry. Key Structural & Conceptual Changes
: A new chapter focusing on the adverse prognostic implications of systemic cancers metastasizing to the skin. WHO Classification of Skin Tumours
: Entities are now generally listed in order from benign to malignant within each section to better reflect their neoplastic progression and clinical aggressiveness. The (5th Edition, 2025) is the authoritative global